Data as of Mar 07
| +0.46 / +2.25%|
Cambrex Corp. is a life sciences company. It provides products, services and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies its products and services worldwide to innovator and generic pharmaceutical companies. It products include active pharmaceutical ingredients (APIs) and intermediates, generic and branded APIs, controlled substances, chiral compounds, high potency and technology-enhanced APIs, and fine chemicals. The company supplies generic and branded APIs for various indications, including pain management, cardiovascular, central nervous system, endocrine, gastrointestinal, integumentary, respiratory and urinary. It sells its products directly, as well as through independent agents to various pharmaceutical and generic drug companies. Cambrex was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in December 1981 and is headquartered in East Rutherford, NJ.
|Steven M. Klosk||President, Chief Executive Officer & Director|
|Shawn P. Cavanagh||Chief Operating Officer & Executive Vice President|
|Gregory P. Sargen||Chief Financial Officer & Executive Vice President|
|Jayne Muir||Head-New Technologies & Market Research|
|William M. Haskel||Secretary, Chief Compliance Officer & Senior VP|